The molecular targets for the diagnosis and treatment of pancreatic cancer.
about
Meta-analysis of phase III randomized trials of molecular targeted therapies for advanced pancreatic cancer.Association of prion protein expression with pancreatic adenocarcinoma survival in the SEER residual tissue repositoryExome sequencing and digital PCR analyses reveal novel mutated genes related to the metastasis of pancreatic ductal adenocarcinoma.The clinical significance and regulation mechanism of hypoxia-inducible factor-1 and miR-191 expression in pancreatic cancer.Clinical features of cystatin A expression in patients with pancreatic ductal adenocarcinoma.
P2860
The molecular targets for the diagnosis and treatment of pancreatic cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The molecular targets for the diagnosis and treatment of pancreatic cancer.
@ast
The molecular targets for the diagnosis and treatment of pancreatic cancer.
@en
The molecular targets for the diagnosis and treatment of pancreatic cancer.
@nl
type
label
The molecular targets for the diagnosis and treatment of pancreatic cancer.
@ast
The molecular targets for the diagnosis and treatment of pancreatic cancer.
@en
The molecular targets for the diagnosis and treatment of pancreatic cancer.
@nl
prefLabel
The molecular targets for the diagnosis and treatment of pancreatic cancer.
@ast
The molecular targets for the diagnosis and treatment of pancreatic cancer.
@en
The molecular targets for the diagnosis and treatment of pancreatic cancer.
@nl
P2093
P2860
P356
P1433
P1476
The molecular targets for the diagnosis and treatment of pancreatic cancer.
@en
P2093
Alexios S Strimpakos
Kostas N Syrigos
Muhammad Wasif Saif
P2860
P304
P356
10.5009/GNL.2010.4.4.433
P577
2010-12-17T00:00:00Z